Diversion Prevention

Diversion Prevention is a regulatory strategy within controlled substances policy that consists of systematic measures designed to intercept and deter the unauthorized channeling of legally produced pharmaceuticals from legitimate medical and scientific channels into illicit distribution or non-medical use.

125

Publications

5K

Citations

373

Authors

217

Institutions

Publications per year

2017–2026

29

Authors

373

  1. SP
    Steven P. Kurtz

    Nova Southeastern University, United States

    8 publications · 560 citations

    8

    h-index

  2. BO
    Brian O’Neal

    The University of Kansas Health System, United States

    7 publications · 117 citations

    7

    h-index

  3. HL
    Hilary L. Surratt

    University of Delaware, United States

    6 publications · 669 citations

    6

    h-index

  4. TJ
    Theodore J. Cicero

    Washington University in St. Louis, United States

    5 publications · 588 citations

    5

    h-index

  5. CH
    Caitlin Hughes

    UNSW Sydney, Australia

    4 publications · 120 citations

    4

    h-index

1–5 of 373

Venues

  1. Journal of Addictive Diseases

    6 publications · 263 citations

    6

    h-index

  2. Hospital Pharmacy

    6 publications · 83 citations

    6

    h-index

  3. International Journal of Drug Policy

    5 publications · 216 citations

    5

    h-index

  4. Journal of Substance Abuse Treatment

    5 publications · 195 citations

    5

    h-index

  5. Drug and Alcohol Review

    5 publications · 166 citations

    5

    h-index

1–5